πŸ‡ΊπŸ‡Έ FDA
Patent

US 12427155

Treatment for tau-related diseases

granted A61KA61K31/536A61P

Quick answer

US patent 12427155 (Treatment for tau-related diseases) held by The Regents of the University of California expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/536, A61P, A61P25/28